American Association for Cancer Research

Inaugural Class of Fellows of the AACR Academy

Bookmark and Share


The inaugural class of Fellows of the AACR Academy consists of 106 individuals, symbolizing the age of the organization upon establishment of the academy.

Future classes of fellows will be elected by a vote of all the Fellows of the AACR Academy.

The inaugural Fellows of the AACR Academy are listed below. Click on the fellow's name to view his/her biography.

Karen H. Antman, M.D., John Sandson professor of health sciences; dean, Boston University School of Medicine; provost, Boston University Medical Campus
 
David Baltimore, Ph.D., Robert Andrews Millikan professor of biology, president emeritus, California Institute of Technology

Françoise Barré-Sinoussi, Ph.D., professor and director, regulation of retroviral infections unit, virology department, Institut Pasteur

Paul Berg, Ph.D., Cahill professor of biochemistry, emeritus, Stanford University School of Medicine

Joseph R. Bertino, M.D., American Cancer Society professor; chief scientific officer, The Cancer Institute of New Jersey; university professor of medicine and pharmacology, UMDNJ-RWJMS; interim director, The Stem Cell Institute of NJ

J. Michael Bishop, M.D., professor, department of microbiology and immunology; director, G. W. Hooper Research Foundation; chancellor emeritus, University of California, San Francisco

Mina J. Bissell, Ph.D., distinguished scientist, life sciences division, Lawrence Berkeley National Laboratory

Elizabeth H. Blackburn, Ph.D., Morris Herzstein endowed chair in biology and physiology and professor, departments of biochemistry/biophysics and microbiology/immunology, University of California, San Francisco

Sydney Brenner, MB.BCh., D.Phil., founder, Acidophil, LLC; senior distinguished fellow of the Crick-Jacobs Center, Salk Institute for Biological Studies

Angela H. Brodie, Ph.D., professor of pharmacology, University of Maryland School of Medicine, and investigator, University of Maryland Marlene and Stewart Greenebaum Cancer Center

Mario R. Capecchi, Ph.D., distinguished professor, human genetics and biology, University of Utah School of Medicine; investigator, Howard Hughes Medical Institute

Webster K. Cavenee, Ph.D., director, Ludwig Institute for Cancer Research; distinguished professor, University of California, San Diego

Martin Chalfie, Ph.D., William R. Kenan Jr. professor of biological sciences, department of biological sciences, Columbia University

Zhu Chen, M.D., Ph.D., vice-chairman, 12th Standing Committee of the National People’s Congress; chairman, 15th Chinese Peasants and Workers Democratic Party, Central Committee

Aaron J. Ciechanover, M.D., D.Sc., distinguished research professor, Technion-Israel Institute of Technology

Bayard D. Clarkson, M.D., member and head, laboratory of hematopoietic cell kinetics, Memorial Sloan-Kettering Cancer Center

Donald S. Coffey, Ph.D., Catherine Iola and J. Smith Michael distinguished professor of urology, Johns Hopkins University School of Medicine

Stanley N. Cohen, M.D., Kwoh-Ting Li professor in the school of medicine, professor of genetics, and professor of medicine, Stanford University

Suzanne Cory, Ph.D., honorary distinguished professorial fellow, molecular genetics of cancer division, Walter and Eliza Hall Institute of Medical Research and vice-chancellor’s fellow, University of Melbourne

Carlo M. Croce, M.D., professor and chair, department of molecular virology, immunology and medical genetics; director, institute of genetics, The Ohio State University School of Medicine

Tom Curran, Ph.D., deputy scientific director, division of cancer pathobiology; Mai and Harry F. West chair in pediatric research, The Children's Hospital of Philadelphia Research Institute; professor of pathology and laboratory medicine, cell and developmental biology, Perelman School of Medicine; associate director, translational genomics, University of Pennsylvania

Brian J. Druker, M.D., director, Knight Cancer Institute, Oregon Health and Science University; JELD-WEN chair of leukemia research; investigator, Howard Hughes Medical Institute

Raymond N. DuBois, M.D., Ph.D., executive director, The Biodesign Institute: Dalton Chair, school of health solutions; Arizona State University

Sir Martin J. Evans, Ph.D., chancellor, Cardiff University

Emmanuel Farber, M.D., Ph.D., chairman emeritus and professor, department of pathology, University of Toronto

Napoleone Ferrara, M.D., distinguished professor of pathology, senior deputy director for basic sciences, Moores Cancer Center, University of California, San Diego

Isaiah J. Fidler, D.V.M., Ph.D., professor, department of cancer biology; R.E. "Bob" Smith distinguished chair in cell biology; head, cancer metastasis laboratory, The University of Texas MD Anderson Cancer Center

Bernard Fisher, M.D., distinguished service professor, department of surgery, University of Pittsburgh

Joseph F. Fraumeni Jr., M.D., M.Sc., senior investigator and advisor, division of cancer epidemiology and genetics, National Cancer Institute

Emil Frei III, M.D., deceased (1924-2013)

Elaine V. Fuchs, Ph.D., Rebecca C. Lancefield professor, laboratory of mammalian cell biology and development, Rockefeller University; investigator, Howard Hughes Medical Institute

Judy E. Garber, M.D., M.P.H., director, Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute; professor of medicine, Harvard Medical School

Walter Gilbert, Ph.D., Carl M. Loeb University Professor Emeritus, department of molecular and cellular biology, Harvard University

Alfred G. Gilman, M.D., Ph.D., regental professor of pharmacology emeritus, University of Texas Southwestern Medical Center

Carol W. Greider, Ph.D., Daniel Nathans professor and director, department of molecular biology and genetics; professor of oncology, Johns Hopkins University School of Medicine

Roger C. L. Guillemin, M.D., Ph.D., distinguished professor, Salk Institute for Biological Studies

Sir John B. Gurdon, D.Phil., distinguished group leader, Wellcome Trust/Cancer Research U.K. Gurdon Institute

William N. Hait, M.D., Ph.D., global head, Janssen Research and Development, LLC

Leland H. Hartwell, Ph.D., Virginia G. Piper chair of personalized medicine, chief scientist, Center for Sustainable Health, Biodesign Institute, Arizona State University; president emeritus, Fred Hutchinson Cancer Research Center

Avram Hershko, M.D., Ph.D., distinguished professor, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology; adjunct professor of pathology, New York University School of Medicine

James F. Holland, M.D., distinguished professor of neoplastic diseases, Mount Sinai Medical Center

Jimmie C. Holland, M.D., Wayne E. Chapman chair in psychiatric oncology; attending psychiatrist, department of psychiatry and behavioral sciences, Memorial Sloan-Kettering Cancer Center

Waun Ki Hong, M.D., vice provost, clinical research; head, division of cancer medicine; Samsung distinguished university chair in cancer medicine, University of Texas MD Anderson Cancer Center

Leroy E. Hood, M.D., Ph.D., president and co-founder, Institute for Systems Biology; full member, University of Washington Molecular and Cellular Biology Program; professor at large, Keck Graduate Institute of Applied Life Sciences

H. Robert Horvitz, Ph.D., David H. Koch professor of biology, Massachusetts Institute of Technology; member, MIT Koch Institute for Integrative Cancer Research; member, MIT McGovern Institute for Brain Research; investigator, Howard Hughes Medical Institute

Susan Band Horwitz, Ph.D., distinguished professor, Rose C. Falkenstein chair in cancer research, associate director for therapeutics, Albert Einstein Cancer Center; co-chair, department of molecular pharmacology, Albert Einstein College of Medicine

Sir Tim Hunt, Ph.D., emeritus group leader, Clare Hall Laboratories, Cancer Research U.K.

Tony Hunter, Ph.D., director, Salk Institute Cancer Center; American Cancer Society professor of molecular and cell biology, Renato Dulbecco chair, The Salk Institute for Biological Studies

Tyler Jacks, Ph.D., director, David H. Koch Institute for Integrative Cancer Research; professor of biology, Massachusetts Institute of Technology; investigator, Howard Hughes Medical Institute

Peter A. Jones, Ph.D., D.Sc., distinguished professor of urology and biochemistry and molecular biology; Mark A., J. Ruth, and Stillman F. Sawyer chair in cancer research, University of Southern California (USC) Norris Comprehensive Cancer Center

V. Craig Jordan, Ph.D., D.Sc., professor of oncology and pharmacology, Vincent T. Lombardi chair of translational cancer research, vice chair, department of oncology; Lombardi Comprehensive Cancer Center, Georgetown University

Yuet Wai Kan, M.D., Louis K. Diamond professor of hematology, departments of laboratory medicine and medicine, University of California, San Francisco

Mary-Claire King, Ph.D., American Cancer Society professor, departments of medicine and genome sciences, University of Washington

Eva Klein, M.D., Ph.D., professor emeritus, department of microbiology, tumor and cell biology, Karolinska Institutet

George Klein, M.D., Ph.D., professor emeritus, department of microbiology, tumor and cell biology, Karolinska Institutet

Alfred G. Knudson Jr., M.D., Ph.D., distinguished scientist and senior advisor to the president, Fox Chase Cancer Center

Brian K. Kobilka, M.D., professor, molecular and cellular physiology and medicine, Stanford University School of Medicine

Margaret L. Kripke, Ph.D., chief scientific officer, Cancer Prevention and Research Institute of Texas; Vivian L. Smith distinguished chair in immunology emerita and professor emerita, department of immunology, and professor emerita, Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center

Philip Leder, M.D., professor emeritus, department of genetics, Harvard Medical School

Robert J. Lefkowitz, M.D., investigator, Howard Hughes Medical Institute; James B. Duke professor of medicine; professor of biochemistry and chemistry, Duke University Medical Center

Arnold J. Levine, Ph.D., professor, Simons Center for Systems Biology, Institute for Advanced Study; professor, Cancer Institute of New Jersey

Lawrence A. Loeb, M.D., Ph.D., professor of pathology, biochemistry and director, Joseph Goldstein Memorial Cancer Research Laboratory, University of Washington School of Medicine

Tak W. Mak, Ph.D., director, Advanced Medical Discovery Institute and director, The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Princess Margaret Cancer Centre; professor, departments of medical biophysics and immunology, University of Toronto

Lynn M. Matrisian, Ph.D., vice president, scientific and medical affairs, Pancreatic Cancer Action Network

Frank McCormick, Ph.D., director, Helen Diller Family Comprehensive Cancer Center; associate dean, School of Medicine, University of California, San Francisco

John Mendelsohn, M.D., director, Sheik Kalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy and past president, MD Anderson Cancer Center

Donald Metcalf, M.D., professor emeritus, University of Melbourne; Carden fellow in cancer research, division of cancer and hematology, the Walter and Eliza Hall Institute of Medical Research

Enrico Mihich, M.D., presidential scholar and special assistant to the president for sponsored research, Dana-Farber Cancer Institute

Beatrice Mintz, Ph.D., professor and Jack Schultz chair in basic research, Fox Chase Cancer Center

Luc Montagnier, M.D., co-founder and president, World Foundation for AIDS Research and Prevention; director of research emeritus, Centre National de la Recherché Scientifique; professor emeritus, Pasteur Institute

Harold L. Moses, M.D., Hortense B. Ingram professor of molecular oncology; professor of cancer biology, medicine and pathology; director emeritus, Vanderbilt-Ingram Comprehensive Cancer Center

Sir Paul M. Nurse, Ph.D., director, Francis Crick Institute, London; president, The Royal Society

Olufunmilayo I. Olopade, M.D., Walter L. Palmer distinguished service professor of medicine and human genetics; associate dean for global health; director, Center for Clinical Cancer Genetics, University of Chicago Pritzker School of Medicine

Arthur B. Pardee, Ph.D., professor of biological chemistry and molecular pharmacology emeritus, Harvard Medical School

Martine J. Piccart, M.D., Ph.D., professor of oncology, Université Libre de Bruxelles; director of medicine, Jules Bordet Institute

Sir Bruce A. J. Ponder, MB.BChir., Ph.D., founding director, Cancer Research UK Cambridge Research Institute; professor and head of oncology, University of Cambridge; honorary consultant physician, Cambridge University Hospitals

Sir Richard J. Roberts, Ph.D., chief scientific officer, New England Biolabs Inc.

Irwin A. Rose, Ph.D., distinguished professor emeritus, department of physiology and biophysics, University of California, Irvine

Janet D. Rowley, M.D., deceased (1925 - 2013)

Frederick Sanger, Ph.D., deceased (1918 - 2013)

Alan C. Sartorelli, Ph.D., Alfred Gilman professor of pharmacology, Yale University School of Medicine

Andrew V. Schally, Ph.D., distinguished medical research scientist; head, Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, Department of Veterans Affairs; Distinguished Leonard M. Miller professor of pathology, Miller School of Medicine, University of Miami

Phillip A. Sharp, Ph.D., institute professor and faculty member, David H. Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology

Charles J. Sherr, M.D., Ph.D., Herrick Foundation chair, department of tumor cell biology, St. Jude Children’s Research Hospital; investigator, Howard Hughes Medical Institute

Osamu Shimomura, Ph.D., distinguished scientist, Marine Biological Laboratory; professor of physiology emeritus, Boston University School of Medicine

Dennis J. Slamon, M.D., Ph.D., director, clinical/translational research; director, Revlon/UCLA Women’s Cancer Research Program, Jonsson Comprehensive Cancer Center; professor of medicine; chief of the division of hematology/oncology; executive vice chair for research, David Geffen School of Medicine, University of California, Los Angeles 

Oliver Smithies, D.Phil., Weatherspoon eminent distinguished professor, University of North Carolina School of Medicine at Chapel Hill

Michael B. Sporn, M.D., professor of pharmacology and medicine, Geisel School of Medicine at Dartmouth

Louise C. Strong, M.D., Sue and Radcliffe Killam chair, department of genetics, and professor, department of genetics, University of Texas MD Anderson Cancer Center

Takashi Sugimura, M.D., president, Toho University; president emeritus, National Cancer Center

Sir John E. Sulston, Ph.D., professor and chair, Institute for Science, Ethics and Innovation, University of Manchester

Jack W. Szostak, Ph.D., investigator, Howard Hughes Medical Institute; professor of genetics, Harvard Medical School; professor of chemistry and chemical biology, Harvard University; Alexander Rick distinguished investigator, department of molecular biology, Massachusetts General Hospital

Roger Y. Tsien, Ph.D., professor of pharmacology, chemistry and biochemistry, University of California, San Diego; investigator, Howard Hughes Medical Institute

Arthur C. Upton, M.D., emeritus professor of environmental medicine and clinical professor of environmental and community medicine, University of Medicine and Dentistry, Robert Wood Johnson Medical School

George F. Vande Woude, Ph.D., distinguished scientific fellow, Van Andel Research Institute

Bert Vogelstein, M.D., Clayton professor of oncology and pathology, Howard Hughes Medical Institute investigator, and director, Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins Kimmel Comprehensive Cancer Center

Peter K. Vogt, Ph.D., executive vice president for scientific affairs; professor, department of molecular and experimental medicine; The Scripps Research Institute

Daniel D. Von Hoff, M.D., physician-in-chief, distinguished professor, Translational Genomics Research Institute; professor of medicine, Mayo Clinic; chief scientific officer, Scottsdale Health Care; professor, University of Arizona College of Pharmacy

Geoffrey M. Wahl, Ph.D., professor, Gene Expression Laboratory; Daniel and Martina Lewis Chair, Salk Institute for Biological Studies

James D. Watson, Ph.D., chancellor emeritus, Cold Spring Harbor Laboratory

Lee W. Wattenberg, M.D., professor of laboratory medicine and pathology emeritus, Masonic Cancer Center, University of Minnesota

Robert A. Weinberg, Ph.D., member, Whitehead Institute for Biomedical Research; professor, department of biology, Massachusetts Institute of Technology; director, Ludwig/MIT Center for Molecular Oncology

John H. Weisburger, Ph.D., deceased (1921 - 2014)

Jane Cooke Wright, M.D., deceased (1919 – 2013)

Shinya Yamanaka, M.D., Ph.D., director and professor, Center for iPS Cell Research and Application, Kyoto University; senior investigator, Gladstone Institute of Cardiovascular Disease; and professor of anatomy, University of California, San Francisco

Harald zur Hausen, M.D., professor emeritus, German Cancer Research Center